연구동향 분석

Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa

조혜현 권계철 김세미 구선회 2014년

논문상세정보
인용/피인용
' Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • exos
  • exou
  • fluoroquinoloneresistance
  • ttsseffectorgenotype
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,583 0

0.0%

' Correlation Between Virulence Genotype and Fluoroquinolone Resistance in Carbapenem-Resistant Pseudomonas aeruginosa' 의 참고문헌

  • Type III secretion/intoxication system important in virulence of Pseudomonas aeruginosa infections in burns
    Holder IA Burns 27 129-130 [2001]
  • Type III secretion machines: bacterial devices for protein delivery into host cells
    Galán JE Science 284 1322-1328 [1999]
  • Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa
    Hauser AR Crit Care Med 30 521-528 [2002]
  • Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections
    Roy-Burman A J Infect Dis 183 1767-1774 [2001]
  • Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance
    Akasaka T Antimicrob Agents Chemother 45 2263-2268 [2001]
  • Type II topoisomerase mutations in ciprofloxacin-resistant strains of Pseudomonas aeruginosa
    Mouneimné H Antimicrob Agents Chemother 43 62-66 [1999]
  • Topoisomerase II and IV quinolone resistance-determining regions in Stenotrophomonas maltophilia clinical isolates with different levels of quinolone susceptibility
    Valdezate S Antimicrob Agents Chemother 46 665-671 [2002]
  • The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective
    Thomson CJ J Antimicrob Chemother 43 SA 31-40 [1999]
  • The exoenzyme S regulon of Pseudomonas aeruginosa
    Frank DW Mol Microbiol 26 621-629 [1997]
  • Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001
    Karlowsky JA Antimicrob Agents Chemother 47 1681-1688 [2003]
  • Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones
    Parry CM Antimicrob Agents Chemother 54 5201-5208 [2010]
  • Selective advantages of two major clones of carbapenem-resistant Pseudomonas aeruginosa isolates (CC235 and CC641) from Korea: antimicrobial resistance, virulence and biofilm-forming activity
    Peck KR JOURNAL OF MEDICAL MICROBIOLOGY 62 1015-1024 [2013]
  • Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia
    Schulert GS J Infect Dis 188 1695-1706 [2003]
  • Role of efflux pumps and mutations in genes for topoisomerase II and IV in fluoroquiniolone-resistant Pseudomonas aeruginosa strains
    Oh H Microb Drug Resist 9 323-328 [2003]
  • Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung
    Shaver CM Infect Immun 72 6969-6977 [2004]
  • Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe
    Hrabák J J Clin Microbiol 49 474-475 [2011]
  • Quinoloneresistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
    Vila J J Antimicrob Chemother 39 757-762 [1997]
  • Pseudomonas aeruginosa-mediated cytotoxicity and invasion correlate with distinct genotypes at the loci encoding exoenzyme S
    Fleiszig SM Infect Immun 65 579-586 [1997]
  • Pseudomonas aeruginosa virulence and therapy: evolving translational strategies
    Veesenmeyer JL Crit Care Med 37 1777-1786 [2009]
  • Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa
    Feltman H Microbiology 147 2659-2669 [2001]
  • Prevalence and Genetic Analysis of Multidrug-Resistant Pseudomonas aeruginosa ST235 Isolated from a Hospital in Korea, 2008-2012
    Kwon KC ANNALS OF CLINICAL AND LABORATORY SCIENCE 43 4 414-419 [2013]
  • Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia
    El Solh AA Am J Respir Crit Care Med 178 513-519 [2008]
  • OprD mutations and inactivation, expression of efflux pumps and AmpC, and metallo-beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa isolates from South Korea
    Ko KS INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 40 168-172 [2012]
  • Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa
    Nakano M Antimicrob Agents Chemother 41 2289-2291 [1997]
  • Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography
    Matsumoto M Int J Antimicrob Agents 40 440-444 [2012]
  • Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals
    Sáenz Y J Antimicrob Chemother 51 1001-1005 [2003]
  • Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas
    Higgins PG Int J Antimicrob Agents 21 409-413 [2003]
  • Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Jalal S Antimicrob Agents Chemother 44 710-712 [2000]
  • Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
    Ruiz J J Antimicrob Chemother 51 1109-1117 [2003]
  • Korean Nationwide Surveillance of Antimicrobial Resistance in 2000 with Special Reference to Vancomycin Resistance in Enterococci, and Expanded- Spectrum Cephalosporin and Imipenem Resistance
    이경원 Yonsei Medical Journal 44 4 571-578 [2003]
  • Increasing Prevalence of Vancomycin-Resistant Enterococcus faecium, Expanded-Spectrum Cephalosporin-Resistant Klebsiella pneumoniae, and Imipenem-Resistant Pseudomonas aeruginosa in Korea
    Lee Kyungwon Journal of Korean Medical Science 19 1 8-14 [2004]
  • Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes
    Hsu DI J Antimicrob Chemother 55 535-541 [2005]
  • Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact
    Gasink LB Am J Med 119 526 19-25 [2006]
  • ExoU is a potent intracellular phospholipase
    Sato H Mol Microbiol 53 1279-1290 [2004]
  • Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa
    Agnello M PLoS One 7 42973- [2012]
  • Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC
    Shultz TR Antimicrob Agents Chemother 45 734-738 [2001]
  • Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa
    Wong-Beringer A Clin Microbiol Infect 14 330-336 [2008]
  • Alterations in the GyrA and GyrB Subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa
    Lee JK INT J ANTIMICROBIAL AGENTS 25 290-295 [2005]
  • Acquisition and evolution of the exoU locus in Pseudomonas aeruginosa
    Kulasekara BR J Bacteriol 188 4037-4050 [2006]